...
首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer
【24h】

Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer

机译:定时自动机与离散事件仿真的比较,以实现基于生物标志物的处理决策的建模:转移阉割前列腺癌的说明

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background With the advent of personalized medicine, the field of health economic modeling is being challenged and the use of patient-level dynamic modeling techniques might be required. Objectives To illustrate the usability of two such techniques, timed automata (TA) and discrete event simulation (DES), for modeling personalized treatment decisions. Methods An early health technology assessment on the use of circulating tumor cells, compared with prostate-specific antigen and bone scintigraphy, to inform treatment decisions in metastatic castration-resistant prostate cancer was performed. Both modeling techniques were assessed quantitatively, in terms of intermediate outcomes (e.g., overtreatment) and health economic outcomes (e.g., net monetary benefit). Qualitatively, among others, model structure, agent interactions, data management (i.e., importing and exporting data), and model transparency were assessed. Results Both models yielded realistic and similar intermediate and health economic outcomes. Overtreatment was reduced by 6.99 and 7.02 weeks by applying circulating tumor cell as a response marker at a net monetary benefit of ?€1033 and ?€1104 for the TA model and the DES model, respectively. Software-specific differences were observed regarding data management features and the support for statistical distributions, which were considered better for the DES software. Regarding method-specific differences, interactions were modeled more straightforward using TA, benefiting from its compositional model structure. Conclusions Both techniques prove suitable for modeling personalized treatment decisions, although DES would be preferred given the current software-specific limitations of TA. When these limitations are resolved, TA would be an interesting modeling alternative if interactions are key or its compositional structure is useful to manage multi-agent complex problems.
机译:摘要背景随着个性化医学的出现,卫生经济建模领域受到挑战,可能需要使用患者级动态建模技术。目的旨在说明两种这样的技术,定时自动机(TA)和离散事件仿真(DES)的可用性,用于建模个性化治疗决策。方法采用循环肿瘤细胞的早期健康技术评估,与前列腺特异性抗原和骨闪烁术相比,进行通知转移性阉割前列腺癌治疗决策。根据中间结果(例如,过度处理)和卫生经济结果(例如,净货币效益),定量评估建模技术。在定性地,在模型结构,代理交互,数据管理(即导入和导出数据)以及模型透明度中,以及模型透明度。结果两种模型都产生了现实和类似的中级和健康经济结果。通过将循环肿瘤细胞作为响应标记作为答案标志物的净货币效益,分别将循环肿瘤细胞作为响应标志物的净货币效益和TA模型和DES模型的净货币效益施用,减少6.99和7.02周。关于数据管理特征和对统计分布的支持,观察到特定于软件的差异,这被认为是DES软件的更好。关于特定方法的差异,使用TA更直接的相互作用,从其组成模型结构受益。结论这两种技术都证明适用于建模个性化治疗决策,尽管鉴于目前的TA的软件特定限制,DES将是优选的。当这些限制得到解决时,TA是一个有趣的建模替代,如果相互作用是关键或其组成结构可用于管理多种子体复杂问题是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号